Winning the go-to-market game: Standing out in tomorrow’s complex healthcare ecosystems

Less than 1 min read

Blog, Commercial, Commercialization & Growth

Ahead of Reuters Pharma 2022, Antonio Iervolino, Partner out of our Putnam London office describes 5 major shifts that pharma companies will have to embrace as they design the path to market for their novel assets and provides an analysis on pharma product launches since 2018, identifying trends and measuring their performance against pre-launch expectations.

Antonio distills the key drivers that are critical in developing a virtuous value creating system and designing impactful go-to-market strategies for tomorrow’s healthcare ecosystems.

Read more on the thoughtful analysis and hear from Antonio at Pharma 2022 next week.

Download the whitepaper.

Insights

More insights.

See all insights

Lori Klein, PharmD

Leading world-class Medical Affairs into the future: Insights from Putnam’s Medical Affairs Leadership Council (Spring 2024)

We recently reconvened our Medical Affairs Leadership Council, discussing top of mind topics with leaders.

Eric Auger

Integrating market access considerations into biopharmaceutical asset investment decisions: Common pain points and best practices

Best practices for navigating challenges in integrating market access into investment decision-making.

Lori Klein, PharmD

Learnings from MAPS Americas 2024

Putnam experts share key learnings coming out of MAPS Americas 2024

Centers of Excellence

AI at Putnam

Open roles